Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Off-season doesn't allow brain to recover from football hits, study says

  • Rapid whole-brain imaging with single cell resolution

  • Trisomy 21: How an extra little chromosome throws entire genome off balance

  • Anti-seizure drug may reduce alcohol consumption, study shows

  • The ilk of human kindness: Older women with gumption score high on compassion

  • Our relationship with God changes when faced with potential romantic rejection

  • Sporting latest tech toy can make you seem more like a leader

  • Progressive neurodegenerative disorder linked to R-loop formation

  • New pain relief targets discovered by researchers

  • Better way to deal with bad memories suggested

  •